US Patent 11129817 Solid dispersion forms of rifaximin
Patent 11129817 was granted and assigned to Salix Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+123 characters)
Article
Patent abstract
Provided herein are solid dispersions comprising rifaximin and pharmaceutical compositions and uses thereof.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Mohammed A. Kabir0
Pam Golden0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111298170
Date of Patent
September 28, 2021
0Patent Application Number
202102120
Date Filed
February 12, 2021
0Official Website
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 30 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11129817 Solid dispersion forms of rifaximin
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11129817
Date of patent
September 28, 2021
Patent application number
20210212
Date Filed
February 12, 2021
Find more entities like US Patent 11129817 Solid dispersion forms of rifaximin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
